Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Topoisomerases are interesting targets for drug discovery. In the present study, we attached saturated carbon atoms to the 10-position of camptothecin and synthesized 10 new camptothecin derivatives from 10-HCPT or SN-38. The activities of new compounds were evaluated both in vitro and in vivo. The most promising compound F10, 7-ethyl-10-(2-oxo-2-(piperidin-1-yl)ethoxy)camptothecin, inhibited cancer cells growth with the IC50 of 0.002, 0.003, 0.011 and 0.081 μM on Raji, HCT116, A549 and Lovo cells, respectively. Meanwhile, oral administration of F10 remarkably suppressed the HCT116-xenograft tumor growth in the nude-mice model at the dosage of 0.5, 2.0 and 8.0 mg/kg in vivo. Intraperitoneal administration of F10 can completely inhibit Raji-xenograft tumor growth in established NPG mouse model at 2.0 and 4.0 mg/kg. In addition, the minimum lethal doses of F10 and SN-38 in mice by intravenous administration were 80 and 40 mg/kg (or 0.155, 0.102 mmol/kg), respectively. The solubility of F10 reached 9.86 μg/mL in a buffer solution of pH 4.5. The oral bioavailability of F10 achieved 22.4% in mice. The molecular docking model revealed that F10 can interact with topoisomerase I-DNA complex. Our findings indicate that F10 is a new orally-oavailable antitumor agent with potent anticancer effect. Furthermore, attaching a ring hydrophobic moiety to the 10-position of camptothecin provides a favorable approach in the optimization of camptothecin. Copyright © 2020 Elsevier Masson SAS. All rights reserved.


Shu Fan, Yong-Xiao Cao, Guang-Yan Li, Hao Lei, Mawusse K I Attiogbe, Jing-Chun Yao, Xue-Yan Yang, Yan-Jie Liu, Yuan-Yuan Hei, Hao Zhang, Lei Cao, Xiao-Yan Zhang, Shuai-Shuai Du, Gui-Min Zhang, San-Qi Zhang. F10, a new camptothecin derivative, was identified as a new orally-bioavailable, potent antitumor agent. European journal of medicinal chemistry. 2020 Sep 15;202:112528

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 32650182

View Full Text